Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
Chemotherapy
|
January 1, 1990
One shot of high-dose amikacin: a working hypothesis
E Yourassowsky, M P Van der Linden, F Crokaert
Antimicrobial Agents and Chemotherapy
|
August 1, 1982
Activities of amoxicillin and clavulanic acid combinations against urinary tract infections
F Crokaert, M P van der Linden, E Yourassowsky
Cancer
|
May 15, 1988
Prolonged survival after resection of a malignant melanoma metastatic to the stomach
J C Pector, F Crokaert, F Lejeune, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1990
Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime
E Yourassowsky, M P van der Linden, F Crokaert
Chemotherapy
|
January 1, 1991
Antibacterial effects of meropenem and imipenem against Haemophilus influenzae
E Yourassowsky, M P Van der Linden, F Crokaert
Chemotherapy
|
January 1, 1989
Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin
E Yourassowsky, M P Van der Linden, F Crokaert
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 1, 1997
Epidemiology of infections in the adult medical intensive care unit of a cancer hospital
T Berghmans, F Crokaert, E Markiewicz, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 1990
Antibacterial effect of meropenem and imipenem on Proteus mirabilis
E Yourassowsky, M P Van der Linden, F Crokaert
Antimicrobial Agents and Chemotherapy
|
January 1, 1992
Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae
E Yourassowsky, M P Van der Linden, F Crokaert
Chemotherapy
|
January 1, 1992
Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
E Yourassowsky, M P Van der Linden, F Crokaert
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
Chemotherapy
|
January 1, 1990
One shot of high-dose amikacin: a working hypothesis
E Yourassowsky, M P Van der Linden, F Crokaert
Antimicrobial Agents and Chemotherapy
|
August 1, 1982
Activities of amoxicillin and clavulanic acid combinations against urinary tract infections
F Crokaert, M P van der Linden, E Yourassowsky
Cancer
|
May 15, 1988
Prolonged survival after resection of a malignant melanoma metastatic to the stomach
J C Pector, F Crokaert, F Lejeune, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1990
Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime
E Yourassowsky, M P van der Linden, F Crokaert
Chemotherapy
|
January 1, 1991
Antibacterial effects of meropenem and imipenem against Haemophilus influenzae
E Yourassowsky, M P Van der Linden, F Crokaert
Chemotherapy
|
January 1, 1989
Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin
E Yourassowsky, M P Van der Linden, F Crokaert
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 1, 1997
Epidemiology of infections in the adult medical intensive care unit of a cancer hospital
T Berghmans, F Crokaert, E Markiewicz, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 1990
Antibacterial effect of meropenem and imipenem on Proteus mirabilis
E Yourassowsky, M P Van der Linden, F Crokaert
Antimicrobial Agents and Chemotherapy
|
January 1, 1992
Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae
E Yourassowsky, M P Van der Linden, F Crokaert
Chemotherapy
|
January 1, 1992
Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
E Yourassowsky, M P Van der Linden, F Crokaert
Page
of 9